Peter Svennilson - Jun 16, 2021 Form 4 Insider Report for Oric Pharmaceuticals, Inc. (ORIC)

Role
Director, 10%+ Owner
Signature
/s/ Dominic Piscitelli, attorney-in-fact
Stock symbol
ORIC
Transactions as of
Jun 16, 2021
Transactions value $
$0
Form type
4
Date filed
6/17/2021, 07:49 PM
Previous filing
Jun 24, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ORIC Stock Option (right to buy) Award $0 +16.6K $0.00 16.6K Jun 16, 2021 Common Stock 16.6K $19.03 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) June 16, 2022 or (ii) the business day prior to the next annual meeting of the Issuer's stockholders that occurs following the date of grant.

Remarks:

Exhibit 24 - Power of Attorney